On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment of coronavirus disease and is seeking strategic collaborations to further develop astaxanthin for COVID-19.

The paper was entitled “Astaxanthin: A safe, natural, and multi-faceted anti-inflammatory for maintaining lung health and possibly minimizing SARS-CoV-2 effects” and can be found at www.cardaxpharma.com/COVID-19.